Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Wednesday, March 27, 2024 to report its fourth quarter and full year 2023 financial results and provide a corporate update.
To access the live conference call, please dial (888) 259-6580 (domestic) or (416) 764-8624 (international) and refer to conference ID 21905455. A webcast of the call will also be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following the call.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RAR? agonist in frontline patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.
Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced the launch of its Customer Experience Center (CEC) in Brazil. ...
Capital Ophthalmic, a leader in the ophthalmic industry with over four decades of expertise, is proud to announce the launch of their comprehensive Preventative Maintenance Programs. These new offerings underscore Capital Ophthalmic's commitment to...
Product: Meat and vegetable products
Issue: Food - Microbial Contamination - Listeria
Distribution:AlbertaBritish ColumbiaPossibly other provinces and territories
See the affected products and product photos for this recall
SOURCE Canadian Food...
On April 27 and 28 at San Francisco's Brava Theatre, Chacruna Institute for Psychedelic Plant Medicines will host its unmissable spring conference: Psychedelic Culture. This year's theme is Cultivating Roots for Cultural Change. Registration is still...
Product: Gift Chocolate
Issue: Food - Allergen - Milk; Food - Allergen - Soy
Distribution: Ontario, Quebec
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)